Slides: Understanding new PCSK9 outcome data: From the LDL-c hypothesis to LDL-c causalitySlides (presentation) - Aug. 26, 2017 - ESC 2017, Barcelona, Spain - John Chapman, PhD - Paris, France - PACE-CME symposium
The slides are prepared and presented by the speaker during a CME accredited symposium: PCSK9 inhibition & Cardiovascular Outcomes: Review of lipid targets and treatment strategies held at ESC 2017 in Barcelona. The slides are an educational service to registered PACE members only. PACE is not responsible for the content, opinions expressed in the slides.
John Chapman is Research Professor at the Pierre and Marie Curie University, and Director Emeritus of the National Institute for Health and Medical Research (INSERM) at the Pitié-Salpêtrière University Hospital in Paris, France.
This symposum was supported by unrestricted educational grants provided by Amgen and Sanofi-Regeneron.
The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-CME.